Syngenta and Lavie Bio announce partnership to discover and develop novel bio-insecticide

Agreement reinforces both companies’ commitment to developing and bringing innovative biological solutions to farmers

Syngenta Crop Protection, a leader in agricultural innovation, and Lavie Bio Ltd., a subsidiary of Evogene Ltd. (Nasdaq: EVGN, TASE: EVGN), and a leading ag-biologicals company, today announced an agreement for the discovery and development of new biological insecticidal solutions.

The collaboration will leverage Lavie Bio’s unique technology platform to rapidly identify and optimize bio-insecticide candidates, as well as Syngenta’s extensive global research, development and commercialization capabilities.

Insects pose a major challenge to the health of crops worldwide, directly injuring plants as they feed on the plant’s stems, fruit and roots, as well as indirectly by transmitting bacterial, viral and fungal infections to crops – costing the global economy an estimated $70 billion a year, according to the UN’s Food and Agriculture Organization. Experts predict such losses will worsen with global warming widening the spread of invasive insect risk and rising resistance to available insecticides.

“Syngenta is a leader in advancing sustainable agriculture and we are thrilled to collaborate with Lavie Bio in biocontrol innovation and bring novel modes of action in the growers’ toolbox to combat insect resistance,” said Camilla Corsi, Global Head of Research at Syngenta Crop Protection. “This collaboration underscores Syngenta’s commitment to collaborating with cutting-edge agricultural technology companies, merging digital and experimental approaches to accelerate and diversify innovation.”

“We’re excited to collaborate with Syngenta, a world leader in agricultural innovation,” said Amit Noam, CEO of Lavie Bio. “Both companies share a mutual commitment to sustainable farming and together, we aim to develop an impactful bio-insecticide product. Lavie Bio’s unique computational capabilities and Syngenta’s vast experience in developing and commercializing innovative products make this partnership significant. We enthusiastically look forward to joining forces to achieve the mutual task of insect management in agriculture.”

About Syngenta Crop Protection 

Syngenta Crop Protection is a leader in agricultural innovation, bringing breakthrough technologies and solutions that enable farmers to grow productively and sustainably. We offer a leading portfolio of crop protection solutions for plant and soil health, as well as digital solutions that transform the decision-making capabilities of farmers. Our 17,900 employees serve to advance agriculture in more than 90 countries around the world. Syngenta Crop Protection is headquartered in Basel, Switzerland, and is part of the Syngenta Group.

About Lavie Bio Ltd 

Lavie Bio, a subsidiary of Evogene Ltd., aims to improve food quality, sustainability, and agriculture productivity through the introduction of microbiome-based ag-biological products. Lavie Bio utilizes a proprietary computational predictive platform, the BDD platform, powered by Evogene’s proprietary MicroBoost AI tech-engine, harnessing the power of big data, artificial intelligence, and advanced informatics, for the discovery, optimization and development of bio-stimulant and bio-pesticide products.

About Evogene Ltd

Evogene (Nasdaq: EVGN, TASE: EVGN) is a computational biology company aiming to revolutionize the development of life-science based products by utilizing cutting edge technologies to increase the probability of success while reducing development time and cost. Evogene established three unique tech-engines – MicroBoost AI, ChemPass AI and GeneRator AI – leveraging Big Data and Artificial Intelligence and incorporating deep multidisciplinary understanding in life sciences. Each tech-engine is focused on the discovery and development of products based on one of the following core components: microbes (MicroBoost AI), small molecules (ChemPass AI), and genetic elements (GeneRator AI).

Evogene uses its tech-engines to develop products through subsidiaries and strategic partnerships. Evogene’s subsidiaries currently utilize the tech-engines to develop human microbiome-based therapeutics by Biomica, ag-biologicals by Lavie Bio, ag-chemicals by AgPlenus, medical cannabis products by Canonic and castor varieties, for the biofuel and other industries, by Casterra.

Source

Syngenta, press release, 2024-02-20.

Supplier

Evogene Ltd.
Food and Agriculture Organization of the United Nations (FAO)
Lavie Bio
Syngenta

Share

Renewable Carbon News – Daily Newsletter

Subscribe to our daily email newsletter – the world's leading newsletter on renewable materials and chemicals

Subscribe